Table: Aska Pharmaceutical Holdings -Q1 group results

ASKA Pharmaceutical Holdings

08/08/2022 07:00

Aug 8 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.27               14.22            57.50    
                 (+7.4 pct)                           (+1.6 pct)  
  Operating          1.66                1.19             4.20    
                 (+40.1 pct)                          (-12.4 pct) 
  Recurring          1.81                1.33             4.30    
                 (+35.8 pct)                          (-11.9 pct) 
  Net                1.32                1.10             3.30    
                 (+20.4 pct)                          (-23.1 pct) 
  EPS             46.94 yen           38.72 yen       116.32 yen  
  Ann Div                             15.00 yen        16.00 yen  
  -Q2 div                             7.00 yen         8.00 yen   
  -Q4 div                             8.00 yen         8.00 yen   
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T